Home : Medical Devices : DES - Drug Eluting Stents
DES - Drug Eluting Stents
Drug eluting stents (DES), also known as medicated or drug-coated stents, are small metal scaffold-like structures that are inserted into the coronary artery heart after balloon angioplasty in order to prevent artery closure. The stents are coated in medications that are intended to prevent restenosis (reblocking of the artery). Popular manufacturers include Boston Scientific, Cordis, and Medtronic. Stents are increasingly common, with market projections of up to $5 billion per year, they have been linked with side effects such as thrombosis, severe allergic reactions, and necessary long-term antiplatelet medication in order to prevent thrombosis. The drug-coated stents have also been linked to a higher death rate due to cardiac events such as heart attack when compared to metal stents without a drug coating.
Fast Facts
| Device name: | DES - Drug Eluting Stents (also known as medicated or drug-coated stents) |
| Manufacturer: | Boston Scientific, Medtronic, Cordis |
| Approved uses: | Prevention of artery closure and restenosis (artery reblocking) post-angioplasty |
| Malfunctions: | Side effects include thrombosis, necessity of long-term antiplatelet therapy to decrease thrombosis risk, and severe allergic reactions |
| Related topics: | Medtronic defibrillator, Guidant defibrillator, Plavix |
Boston Scientific Recalls Heart Stent
NexStent Carotid Stent Recall On August 14, 2008, the Food and Drug Administration announced that Boston Scientific has recalled NexStent Carotid Stents and Monorail Delivery Systems distributed... read more
DES (Drug-Eluting Stents) Linked To Serious Side Effects
It is a $5 billion/year industry, and over six million American patients have been treated with drug-eluting stents (DES) after balloon angioplasty procedures. But DES treatment is coming under fire... read more
View the DES - Drug Eluting Stents Main Articles page here
Government Articles Related to DES - Drug Eluting Stents
New Drug Approval: CYPHERâ„¢ Sirolimus-eluting Coronary Stent - P020026
FDA Statement on Coronary Drug-Eluting Stents
View the DES - Drug Eluting Stents Government Articles page here
MSN Newsfeeds Related to DES - Drug Eluting Stents
Johnson & Johnson Reports Fourth-Quarter and Full-Year 2007 Results
Critics troubled by ads pitching medical devices
View the DES - Drug Eluting Stents MSN Newsfeeds page here
News Articles Related to DES - Drug Eluting Stents
Omnicell Reports Second Quarter 2008 Results - MarketWatch
View the DES - Drug Eluting Stents News Articles page here
Books Related to DES - Drug Eluting Stents
Handbook of Drug-Eluting Stents
Colombo's Tips & Tricks for Drug Eluting Stents
View the DES - Drug Eluting Stents Books page here






